Activity
-
I enjoyed talking to Dr. Alexander Schacht about benefit-risk assessment and patient preferences in drug development. If you're interested in either…
I enjoyed talking to Dr. Alexander Schacht about benefit-risk assessment and patient preferences in drug development. If you're interested in either…
Liked by Brad Mason
-
How can #patientexperiencedata and #patientpreferences inform #benefitriskassessment and broader #drugdevelopment and #regulatorydevisionmaking at…
How can #patientexperiencedata and #patientpreferences inform #benefitriskassessment and broader #drugdevelopment and #regulatorydevisionmaking at…
Liked by Brad Mason
-
That is a wrap for Health Technology Assessment international (HTAi) 2024 in Seville. It was a great conference. I wanted to share some of my…
That is a wrap for Health Technology Assessment international (HTAi) 2024 in Seville. It was a great conference. I wanted to share some of my…
Liked by Brad Mason
Projects
-
Drug repurposing
-
Final year project
-
Impact of next-generation sequencing on achieving precision medicine
-
Literature review
More activity by Brad
-
The Adelphi Values Patient-Centered Outcomes team are pleased to share a publication in #diabetes and #obesity. Open access article here:…
The Adelphi Values Patient-Centered Outcomes team are pleased to share a publication in #diabetes and #obesity. Open access article here:…
Liked by Brad Mason
-
Insights from patients gathered early in product development can provide vital information to aid early decisions. It is now widely accepted that…
Insights from patients gathered early in product development can provide vital information to aid early decisions. It is now widely accepted that…
Liked by Brad Mason
-
More than a Checkbox. Stop Making Assumptions! The Power of Pretesting in Patient-Centric Research Have you ever felt like the surveys you…
More than a Checkbox. Stop Making Assumptions! The Power of Pretesting in Patient-Centric Research Have you ever felt like the surveys you…
Liked by Brad Mason
-
Great point in these slides; In my view a similar process should be followed when developing preference studies, adding that each translation and…
Great point in these slides; In my view a similar process should be followed when developing preference studies, adding that each translation and…
Liked by Brad Mason
-
There are only a few more days until #ISPORAnnual. I look forward to meeting old friends and colleagues and making new connections. If you're…
There are only a few more days until #ISPORAnnual. I look forward to meeting old friends and colleagues and making new connections. If you're…
Liked by Brad Mason
-
Finally Available: An Accessible Introduction to Multidimensional Thresholding (MDT)! If you want to try the preference elicitation method yourself…
Finally Available: An Accessible Introduction to Multidimensional Thresholding (MDT)! If you want to try the preference elicitation method yourself…
Liked by Brad Mason
-
Preference studies in regulatory and payer’s decisions. On my way to DIA Europe 2024, to take part in a panel discussion about when, how and why the…
Preference studies in regulatory and payer’s decisions. On my way to DIA Europe 2024, to take part in a panel discussion about when, how and why the…
Liked by Brad Mason
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Brad Mason in United Kingdom
-
Brad Mason
Chief Engineer at Airbus Defence and Space
-
Brad Mason
Contract Supervisor @ Masons Scaffolding
-
Brad Mason
Middle Office Coordinator
-
Brad Mason
Works Manager at CNC Support
37 others named Brad Mason in United Kingdom are on LinkedIn
See others named Brad Mason